(Press-News.org) Some of the most effective and expensive cancer drugs, dubbed "smart drugs" for their ability to stop tumors by targeting key drivers of cancer cell growth, are not effective in some patients. In two related studies, Yale School of Medicine researchers examined one such driver, the EGF receptor (EGFR), and found that a decoy receptor might be limiting the amount of drug that gets to the intended target.
"We know that smart drugs like Cetuximab are not always effective in the cancer cells they're supposed to target because there are no positive predictive markers for selecting the patients who will benefit from treatment with EGFR-targeted therapies, including EGFR itself," said lead author Nita Maihle, professor in the Departments of Obstetrics, Gynecology & Reproductive Sciences and of Pathology at Yale School of Medicine. "Why would a patient be given an expensive drug if it doesn't work? Our studies provide new insight into this paradoxical EGFR testing conundrum."
In a study published recently in the journal Cancer, Maihle and her team isolated a protein from human blood that looks like EGFR, but is actually a closely related variant called serum sEGFR. They showed that Cetuximab binds equally as well to serum sEGFR as it does to the intended EGFR cancer target.
Those study results showed that sEGFR might act as a decoy receptor in the blood of cancer patients, tying up Cetuximab and therefore limiting the amount of Cetuximab that actually gets to the intended target.
Such limitations may, in part, provide an explanation for the failure of two large phase III clinical trials on Cetuximab in colorectal cancer patients, since serum sEGFR concentrations are highly variable in cancer patients. These studies suggest that serum sEGFR should be measured and considered prior to treatment with Cetuximab. Other research has supported this concept by showing that serum sEGFR concentration changes in response to treatment with Cetuximab.
In their second related study, published online in the current issue of the journal Biochemistry, Maihle and her team show that newly developed reagents to measure sEGFR in blood and other human tissues can detect a second unrelated cell surface protein in tumor cells: alpha-5 integrin.
"This important finding suggests that the naturally occurring sEGFR protein may play a complex role in cell adhesion and migration—two cellular processes important in the spread of cancer," said Maihle, who is a member of Yale Cancer Center. "Together these studies demonstrate an unanticipated level of complexity in EGFR signaling and assay development, and suggest new ways to overcome current challenges associated with clinical testing for this important cancer target."
###
The studies were funded by the National Cancer Institute, Susan G. Komen for the Cure, and the Marsha Rivkin Center for Ovarian Cancer Research.
Other authors on the Biochemistry study include Jason A. Wilken, Andre T. Baron, Ramsey A. Foty and Daniel J. McCormick.
Yale researchers explain why cancer 'smart drugs' may not be so smart
2011-05-11
ELSE PRESS RELEASES FROM THIS DATE:
Reforesting rural lands in China pays big dividends, Stanford researchers say
2011-05-11
An innovative program to encourage sustainable farming in rural China has helped restore eroded forestland while producing economic gains for many farmers, according to a new study by Stanford University researchers.
Their findings are published in the Proceedings of the National Academy of Sciences (PNAS).
"The Sloping Land Conversion Program, which began in 2000 after massive flooding caused in part by land clearing, focuses on China's largest source of soil erosion and flood risk – farms on steep slopes," said study co-author Gretchen Daily, a professor of biology ...
Webcast Discussing Judge Scheindlin's Recent NDLON Ruling on ESI Productions and Metadata Now Available Online
2011-05-11
ZyLAB, a leading eDiscovery and information management technology company, today announced that the popular webcast titled "Contemporary Productions and Metadata for 21st Century Disclosures" is now available on demand from the company's website. The lively and informative 80-minute webcast addresses the controversy surrounding the recent ruling in the National Day Laborer Organizing Network (NDLON) v. US Immigration and Customs Enforcement Agency (ICE) case involving ESI productions and metadata.
NDLON plaintiff counsel, Anthony Diana, of Mayer Brown LLP, ...
Practice, not loss of sight, improves sense of touch in the blind: study
2011-05-11
New research from McMaster University may answer a controversial question: do the blind have a better sense of touch because the brain compensates for vision loss or because of heavy reliance on their fingertips?
The study, published in the most recent edition of the Journal of Neuroscience, suggests daily dependence on touch is the answer.
Twenty-eight profoundly blind participants—with varying degrees of Braille expertise—and 55 normally sighted adults were tested for touch sensitivity on six fingers and both sides of the lower lip.
Researchers reasoned that, ...
Vitamins may hitch a protected ride on corn starch
2011-05-11
Vitamins and medications may one day take rides on starch compounds creating stable vitamin-enriched ingredients and cheaper controlled-release drugs, according to Penn State food scientists.
The technique may offer drug and food companies a less expensive, more environmentally friendly alternative in creating, among other products, medications and food supplements.
In a series of experiments, researchers formed pockets with corn starch and a fatty acid ester to carry oil soluble vitamins, such as vitamin A and vitamin C, into the body, according to Gregory Ziegler, ...
Results from study of 8,000 older people in Ireland launched
2011-05-11
The first results from The Irish Longitudinal Study on Ageing (TILDA), a national study of 8,000 older people aged 50 and over in Ireland, were launched this week by the Minister for Health and Children, Dr James Reilly.
TILDA is the most comprehensive study ever conducted on ageing in Ireland. Between 2009- 2011, over 8,000 people aged 50 and over were randomly selected across the country and interviewed about many aspects of their lives including issues such as health, financial circumstances and quality of life. Almost 85 per cent of the participants also underwent ...
When words get hot, mental multitaskers collect cool
2011-05-11
How useful would it be to anticipate how well someone will control their emotions? To predict how well they might be able to stay calm during stress? To accept critical feedback stoically?
Heath A. Demaree, professor of psychology at Case Western Reserve University, finds clues in what psychologists call "hot" and "cold" psychology.
"People differ with regard to how well they can control their emotions, and one factor that predicts it is non-emotional in nature – it is a 'cold' cognitive construct," Demaree explains referring to Working Memory Capacity.
Working ...
Toward a vaccine for methamphetamine abuse
2011-05-11
Scientists are reporting development of three promising formulations that could be used in a vaccine to treat methamphetamine addiction — one of the most serious drug abuse problems in the U.S. The report appears in the Journal of the American Chemical Society.
In the paper, Kim Janda and colleagues note that methamphetamine use and addiction cost the U.S. more than $23 billion annually due to medical and law enforcement expenses, as well as lost productivity. The drug, also called "meth" or "crystal meth," can cause a variety of problems including cardiovascular damage ...
Finding reserves on the electrical grid
2011-05-11
This release is available in German.
When storms lash northern and eastern Germany, it regularly gets tight in the high-voltage and highest-voltage electrical grids. Electricity from renewable resources has priority on the grid. But, on stormy days in particular, wind turbine systems must be taken offline, because the gird capacities are insufficient. "Currently we are in a situation where we have high inflows from renewable energies into our high voltage line system and are expecting large increases in the future. However, the grid is not designed for this level of ...
Software for the discovery of new crystal structures
2011-05-11
A new software called QED (Quantitative Electron Diffraction), which has been licensed by Max Planck Innovation, has now been released by HREM Research Inc., a Japan based company, which is developing products and services in the field of High-Resolution Electron Microscopy. QED allows transmission electron microscopes to acquire novel kinds of data, opening up new possibilities in electron crystallography.
Transmission electron microscopes create magnified images of samples and are, in contrast to the light microscope, even able to resolve individual atoms. When transmitting ...
Mini Cities to Present at NYC Early-Stage Angel and Venture Capital Event
2011-05-11
Mini Cities announces that on Thursday, May 12, 2011 it will be presenting at the NYC Early-Stage Angel and Venture Capital Event hosted by FundingPost. "We are very excited to be able to pitch Mini Cities to such a great group of investors." Said Ana Abraham, founder of MiniCities.com. "Mini Cities is in a great space right now with the acquisition of Patch and Bckyrd.com we are in the right market at the right time."
Mini Cities is built on a proprietary multi-tiered multitenant platform. Each Mini Cities site is a hyperlocal destination site for ...